Healthpeak Properties (DOC)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-07-07
$21.95+0.90%
Close 2026-07-07 · 1-day change
Reading DOC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DOC free→NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-07-07
Reading DOC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DOC free→Healthpeak Properties has stable earnings with EPS guidance raised to $0.48 for 2026. The company reaffirms its 2026 FFO guidance at $1.68 to $1.72 per share. Revenue growth is modest but steady at about 1.7% expected for 2026. The balance sheet is strong, supporting growth and dividend payments near 6%.
Revenue growth is very low at about 1.7%, limiting upside. The stock trades at a high PE of 84.4, which is expensive versus peers. EPS estimates have been lowered recently, signaling risk to earnings. Any sustained decline in NOI or FFO would pressure dividends and valuation.
The price is about 1% above our fair value near $21. Analysts expect roughly 1.7% revenue growth in 2026. Our fair value aligns with the Street median, reflecting modest growth and stable income. We see limited upside beyond current expectations.
Breaks if: Significant deterioration in credit ratings or liquidity
Breaks if: EPS falls below $0.46 in FY26
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Healthpeak has updated its 2026 EPS guidance to a range of $0.46 to $0.50.
Breaks if: FFO per share falls below $1.68 in FY26
Healthpeak reaffirms its 2026 FFO guidance in the range of $1.68 to $1.72 per share.
Breaks if: Revenue growth falls below 1.7% in FY26
Healthpeak continues to reaffirm its 2026 NOI growth guidance in the range of -1.0% to 1.0%.